The Department of Human Oncology at the University of Wisconsin-Madison has chosen RayStation as its next radiation therapy treatment planning system. The agreement was signed in late December 2016, and the purchase is planned to occur in two phases.

Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were published online in Annals of Emergency Medicine ("Risk of Acute Kidney Injury Following Intravenous Contrast Media Administration").

IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016, following the receipt of regulatory approvals.

Arterys, Cardiac MRI, cardiac MRI advances
Toshiba Infinix-i Sky
GE Vivid iq compact cardiovascular ultrasound
Siemens Artis pheno angiography system

Each year imaging system manufacturers use the Radiological Society of North America (RSNA) meeting at the end of the year to unveil their latest technologies. RSNA 2016 included several new cardiovascular imaging advancements.

Watch the video “Editor's Choice of the Most Innovative New Technology at RSNA 2016” to see examples of some of the technologies discussed below. 

Speeding Cardiac MRI Workflow

January 27, 2017 — Market intelligence firm Infiniti Research released a new report on the growth of 3-D mammography (tomosynthesis) in the United States, highlighting the benefits and acknowledging the barriers to continued adoption.

The following are excerpts from the report:

Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment on a Mevion S250 proton therapy system in conjunction with Airo, a mobile, diagnostic computed tomography (CT) scanner. The advanced 3D CT-based localization is integrated to Verity Patient Positioning System, a component of the Mevion S250 Series, and is based on high-precision stereotactic localization and tracking technology. This solution improves treatment accuracy and reduces patient positioning uncertainties.

Researchers have developed the first sensor capable of objectively identifying inflammatory bowel disease (IBD) and distinguishing between its two subtypes. The device represents a substantial achievement toward a more personalized approach to diagnosing and treating IBD, a chronic inflammation of the gastrointestinal tract affecting more than 1 million Americans.

Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging, Indiana-based Major Health Partners (MHP) has purchased and installed Gamma Medica’s LumaGEM molecular breast imaging (MBI) system. It is the state’s first LumaGEM and the hospital’s first MBI.

Siemens Healthineers has announced the expansion of its online learning platform PEPconnect (Personalized Education Plan) to include approximately 1,000 new learning modules for medical imaging customers. Effective immediately, physicians and medical technology assistants can use PEPconnect to access training courses on Siemens Healthineers systems for imaging and minimally invasive therapy in seven different languages: English, German, French, Italian, Spanish, Korean and Japanese.

Accuray Inc. announced recently that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating patients using the new Radixact Treatment Delivery System, fully integrated with the new Accuray Precision Treatment Planning System and iDMS Data Management System.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now